Suchergebnisse - "Schloemer, Patrick"

PubPharm (10)

1

Validation of the Klinrisk chronic kidney disease progression model in the FIDELITY population

enthalten in: Clinical kidney journal | 2024

von Tangri, N. | Ferguson, T. | Leon, S. | +11

2

Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression : A Review

enthalten in: Journal of the American Society of Nephrology : JASN | 2023

von Little, D. | Gasparyan, S. | Schloemer, P. | +9

3

Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression

enthalten in: Journal of the American Society of Nephrology : JASN | 2023

von Heerspink, H. | Jongs, N. | Schloemer, P. | +10

4

Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials

enthalten in: Kidney international | 2023

von Heerspink, H. | Jongs, N. | Neuen, B. | +9

CommentIn: Kidney Int. 2023 Sep;104(3):617. - PMID 37599021

5

Cardiovascular Events with Finerenone in CKD and Diabetes. Reply

enthalten in: The New England journal of medicine | 2022

von Pitt, B. | Joseph, A. | Schloemer, P.

CommentOn: N Engl J Med. 2022 Apr 21;386(16):e43. - PMID 35443116

6

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes

enthalten in: The New England journal of medicine | 2021

von Pitt, B. | Filippatos, G. | Agarwal, R. | +109

CommentIn: Nat Rev Cardiol. 2021 Nov;18(11):738. - PMID 34508230

7

Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes

enthalten in: Circulation | 2021

von Filippatos, G. | Anker, S. | Agarwal, R. | +9

CommentIn: Circulation. 2021 Sep 14;144(11):e201. - PMID 34516302

8

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

enthalten in: The New England journal of medicine | 2020

von Bakris, G. | Agarwal, R. | Anker, S. | +109

CommentIn: N Engl J Med. 2020 Dec 3;383(23):2285-2286. - PMID 33095527

9

Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial

enthalten in: American journal of nephrology | 2019

von Bakris, G. | Agarwal, R. | Anker, S. | +109

10

Spinal high-velocity low amplitude manipulation in acute nonspecific low back pain : a double-blinded randomized controlled trial in comparison with diclofenac and placebo

enthalten in: Spine | 2013

von von Heymann, W. | Schloemer, P. | Timm, J. | +1

1
[1]